Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/19639
Title: Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population.
Authors: 
Keywords: 
Issue Date: 2016
Citation: Patient Prefer Adherence.2016;(10):1-7
Abstract: In oncology, establishing the value of new cancer treatments is challenging. A clear definition of the different perspectives regarding the drivers of innovation in oncology is required to enable new cancer treatments to be properly rewarded for the value they create. The aim of this study was to analyze the views of oncologists, health care policy makers, patients, and the general population regarding the value of new cancer treatments.
PMID: 26719677
URI: https://hdl.handle.net/20.500.12530/19639
Rights: openAccess
ISSN: 1177-889X
Appears in Collections:Hospitales > H. U. Puerta de Hierro Majadahonda > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Puerta de Hierro-Segovia de Arana > Artículos

Files in This Item:
File Description SizeFormat 
PMC4690649.pdf255.97 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.